Corona Virus Illness-2019 (COVID-19) has unfold extensively all through the world for the reason that finish of 2019. Nucleic acid testing (NAT) has performed an essential function in affected person analysis and administration of COVID-19. In some circumstances, thermal inactivation at 56 °C has been beneficial to inactivate Extreme Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) earlier than NAT. Nevertheless, this process might theoretically disrupt nucleic acid integrity of this single-stranded RNA virus and trigger false negatives in real-time polymerase chain response (RT–PCR) assessments.
We investigated whether or not thermal inactivation might have an effect on the outcomes of viral NAT. We examined the consequences of thermal inactivation on the quantitative RT–PCR outcomes of SARS-CoV-2 significantly with regard to the charges of false-negative outcomes for specimens carrying low viral masses. We moreover investigated the consequences of various specimen sorts, pattern preservation occasions and a chemical inactivation strategy on NAT.Our work confirmed elevated Ct values in specimens from identified COVID-19 sufferers in RT–PCR assessments after thermal incubation.
Furthermore, about half of the weak-positive samples (7 of 15 samples, 46.7%) had been RT–PCR destructive after warmth inactivation in a minimum of one parallel testing. The usage of guanidinium-based lysis for preservation of those specimens had a smaller influence on RT–PCR outcomes with fewer false negatives (2 of 15 samples, 13.3%) and considerably much less enhance in Ct values than warmth inactivation.Thermal inactivation adversely affected the effectivity of RT–PCR for SARS-CoV-2 detection. Given the restricted applicability related to chemical inactivators, different approaches to make sure the general safety of laboratory personnel want consideration.
A novel pure antisense transcript at human SOX9 locus is down-regulated in most cancers and stem cells.
SOX9 is a key transcription issue with essential roles in regulating proliferation and differentiation of varied cell sorts. Dysregulation of SOX9 expression has been concerned with pathogenesis of various developmental, degenerative, and neoplastic issues. Pure antisense transcripts (NATs) are lengthy non-coding RNAs with rising significance in regulation of gene expression. Nevertheless, the presence of a NAT at SOX9 locus has been to date unclear.We detected a pure antisense transcript at SOX9 locus (SOX9-NAT) by means of strand-specific RT–PCR.
In distinction to SOX9 sense RNA (mRNA), SOX9-NAT was down-regulated in most cancers tissues and cell strains in contrast with their regular counterparts. As well as, reciprocal to SOX9 mRNA, SOX9-NAT was additionally down-regulated in human embryonic stem cells compared with human fibroblasts in vitro.The destructive correlation between SOX9 mRNA and SOX9-NAT was confirmed by analyzing qPCR knowledge, in addition to RNA-Seq datasets of a number of human cancers. Our knowledge recommend a practical function for SOX9-NAT within the regulation of SOX9 mRNA as a possible goal in most cancers remedy and regenerative drugs.
Hepatitis B viral an infection has been transmitted from donors with HBV infections who’ve destructive HBs Ag. Many international locations have applied nucleic acid testing (NAT) to display screen donors with non- reactive HBs Ag for detection of HBV DNA and improve security of blood transfusion, whereas it’s restricted to restricted blood banks in Egypt.To guage the importance of NAT know-how in detection of HBV DNA within the Egyptian blood donors with HBs Ag non- reactivity.The research included 36,584 collected blood samples from volunteer blood donors on the blood financial institution of Zagazig College Hospitals.
Every specimen was examined for HBs Ag; non- reactive sera had been additional examined for qualitative detection of HBV-DNA by NAT testing. All optimistic HBV-DNA donors had been examined for anti- HBc and anti- HBs by electro-chemiluminescence immunoassay and confirmed by quantitative RT–PCR.Amongst 34,671 donors non-reactive to HBs Ag, 34,657 (99.96%) had been examined destructive for HBV- DNA and 14 specimens (0.04%) had been optimistic for HBV through NAT testing.
Amongst HBV NAT optimistic donors, HBs Ab reactive solely in (2); HBc Ab reactive solely in (3); HBs and HBc Abs reactive in (3) whereas HBs and HBc Ab non-reactive in (6). All examined sera 14 (100%) confirmed low viral load for HBV (<50 IU/ml) confirmed by RT– qPCR.Our outcomes highlighted the importance of the HBV NAT method to scale back the potential threat of HBV transfusion-transmission and the important have to implement the utilization of NAT know-how in all blood banks in Egypt.
Rumen-Protected 5-Hydroxytryptophan Improves Sheep Melatonin Synthesis within the Pineal Gland and Intestinal Tract.
Primarily based on the in depth organic results of melatonin (MLT), it’s helpful to extend the MLT content material within the our bodies of animals at a selected physiological stage. This research was carried out to research the impact of a weight loss program supplemented with rumen-protected (RP) 5-hydroxytryptophan (5-HTP) on the pineal gland and intestinal tract MLT synthesis of sheep. Eighteen Kazakh sheep had been assigned randomly to three weight loss program teams: management group (CT, corn-soybean meal basal weight loss program), CT+111 group, and CT+222 group.
The gene expressions of fragrant amino acid decarboxylase (AADC), arylalkylamine N-acetyltransferase (AA-NAT), hydroxyindole-O-methyltransferase (HIOMT), monoamine oxidase A (MAOA), and the intermediates of MLT synthesis had been noticed from the pineal gland and intestinal tract by the reverse transcription (RT)-PCR methodology. The 5-HTP, 5-HT, N-acetylserotonin, MLT, and 5-hydroxyindole acetic acid (5-HIAA) contents within the pineal gland and intestinal tract had been analyzed by ultra-high-performance liquid chromatography-tandem mass spectrometry. RESULTS The research confirmed that the pineal gland HIOMT expression (P<0.05)
 PMAxx) PMA Real-Time PCR Bacterial Viability Kit - E. coli (uidA) PMAxx |
|||
| 31050-X | Biotium | 1kit | EUR 428 |
|
Description: Minimum order quantity: 1 unit of 1kit |
|||
 PMAxx) PMA Real-Time PCR Bacterial Viability Kit - E. coli O157:H7 (Z3276) PMAxx |
|||
| 31037-X | Biotium | 1kit | EUR 428 |
|
Description: Minimum order quantity: 1 unit of 1kit |
|||
 host cell proteins (HCPs) ELISA kit, 96 tests) E Coli proteins (5 strains) host cell proteins (HCPs) ELISA kit, 96 tests |
|||
| 800-130-ECP | Alpha Diagnostics | 1 Kit | EUR 834 |
 E. coli RecA Protein |
|||
| 01-001 | Sceti | 200 ug | EUR 205 |
|
Description: The E. coli RecA Protein is available in Europe and for worldwide shipping via Gentaur. |
|||
 E. coli RuvA protein |
|||
| 01-007 | Sceti | 50 ug | EUR 479 |
|
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
|||
E. coli RuvA protein |
|||
| 01-008 | Sceti | 250 ug | EUR 1184 |
|
Description: The E. coli RuvA protein is available in Europe and for worldwide shipping via Gentaur. |
|||
 E. coli RuvB protein |
|||
| 01-009 | Sceti | 50 ug | EUR 479 |
|
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
|||
E. coli RuvB protein |
|||
| 01-010 | Sceti | 250 ug | EUR 1184 |
|
Description: The E. coli RuvB protein is available in Europe and for worldwide shipping via Gentaur. |
|||
 E. coli RuvC protein |
|||
| 01-011 | Sceti | 50 ug | EUR 479 |
|
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
|||
E. coli RuvC protein |
|||
| 01-012 | Sceti | 250 ug | EUR 1184 |
|
Description: The E. coli RuvC protein is available in Europe and for worldwide shipping via Gentaur. |
|||
 RecA Protein E. coli |
|||
| M1231-200 | Biovision | EUR 202 | |
 Yellow Fluorescent Proteins (YFP) protein control for Western blot) Recombinant (E. coli) Yellow Fluorescent Proteins (YFP) protein control for Western blot |
|||
| YFP11-C | Alpha Diagnostics | 100 ul | EUR 286 |
 Antibody) Escherichia coli (E. coli) Antibody |
|||
| abx411320-1ml | Abbexa | 1 ml | EUR 509 |
|
|||
Escherichia coli (E. coli) Antibody |
|||
| abx415692-01mg | Abbexa | 0.1 mg | EUR 634 |
|
|||
Escherichia coli (E. coli) Antibody |
|||
| abx415712-1ml | Abbexa | 1 ml | EUR 606 |
|
|||
 E. coli Antibody |
|||
| abx021669-1mg | Abbexa | 1 mg | EUR 1295 |
|
|||
E. coli Antibody |
|||
| abx021670-1mg | Abbexa | 1 mg | EUR 871 |
|
|||
E. coli Antibody |
|||
| abx021671-02ml | Abbexa | 0.2 ml | EUR 495 |
|
|||
E. coli Antibody |
|||
| abx021672-1mg | Abbexa | 1 mg | EUR 871 |
|
|||
E. coli Antibody |
|||
| abx021673-1mg | Abbexa | 1 mg | EUR 871 |
|
|||
E. coli Antibody |
|||
| abx022970-1ml | Abbexa | 1 ml | EUR 732 |
|
|||
E. coli Antibody |
|||
| abx022971-1ml | Abbexa | 1 ml | EUR 968 |
|
|||
E. coli Antibody |
|||
| abx022975-1ml | Abbexa | 1 ml | EUR 599 |
|
|||
E. coli Antibody |
|||
| abx022977-1ml | Abbexa | 1 ml | EUR 676 |
|
|||
 E. coli antibody |
|||
| 10C-CR1244M1 | Fitzgerald | 100 ug | EUR 408 |
|
Description: Mouse monoclonal E. coli antibody |
|||
E. coli antibody |
|||
| 10-E09C | Fitzgerald | 100 ug | EUR 133 |
|
Description: Mouse monoclonal E. coli antibody |
|||
E. coli antibody |
|||
| 10-E10A | Fitzgerald | 500 ug | EUR 493 |
|
Description: Mouse monoclonal E. coli antibody |
|||
E. coli antibody |
|||
| 10-E10B | Fitzgerald | 500 ug | EUR 493 |
|
Description: Mouse monoclonal E. coli antibody |
|||
E. coli antibody |
|||
| 20C-CR1244GP | Fitzgerald | 1 ml | EUR 468 |
|
Description: Goat polyclonal E. coli antibody |
|||
E. coli antibody |
|||
| 20-ER13 | Fitzgerald | 1 ml | EUR 355 |
|
Description: Rabbit polyclonal E. coli antibody |
|||
 E. coli GroL |
|||
| DAG1704 | Creative Diagnostics | 100 ug | EUR 915 |
 E. coli GroS |
|||
| DAG1705 | Creative Diagnostics | 100 ug | EUR 915 |
 E. coli DsbA |
|||
| DAG1712 | Creative Diagnostics | 100 ug | EUR 915 |
 E. coli GrpE |
|||
| DAG1714 | Creative Diagnostics | 100 ug | EUR 1027 |
 Yellow Fluorescent Proteins (YFP) protein for ELISA or Standards (>98%)) Recombinant (E. coli) Yellow Fluorescent Proteins (YFP) protein for ELISA or Standards (>98%) |
|||
| YFP15-R | Alpha Diagnostics | 25 ug | EUR 250 |
 E. Coli O 157 Protein |
|||
| abx061475-01ml | Abbexa | 0.1 ml | EUR 551 |
|
|||
 Antibody (Biotin)) Escherichia coli (E. coli) Antibody (Biotin) |
|||
| abx411321-1ml | Abbexa | 1 ml | EUR 592 |
|
|||
 Antibody (FITC)) Escherichia coli (E. coli) Antibody (FITC) |
|||
| abx411322-1ml | Abbexa | 1 ml | EUR 509 |
|
|||
Escherichia coli (E. coli) Antibody (Biotin) |
|||
| abx415713-1ml | Abbexa | 1 ml | EUR 718 |
|
|||
 Red Fluorescent Proteins (RFP/dsRed) protein for ELISA or Standards (>98%)) Recombinant (E. coli) Red Fluorescent Proteins (RFP/dsRed) protein for ELISA or Standards (>98%) |
|||
| RFP15-R | Alpha Diagnostics | 25 ug | EUR 250 |
 Protein) E. coli Protein GrpE (GrpE) Protein |
|||
| 20-abx261718 | Abbexa |
|
|
|
|||
) Enterotoxin STp (E. coli) |
|||
| H-6248.0500 | Bachem | 0.5mg | EUR 696 |
|
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
|||
Enterotoxin STp (E. coli) |
|||
| H-6248.1000 | Bachem | 1.0mg | EUR 1180 |
|
Description: Sum Formula: C81H110N20O26S6; CAS# [115474-04-9] net |
|||
 E. coli O157 Antibody |
|||
| abx021684-1mg | Abbexa | 1 mg | EUR 1017 |
|
|||
E. coli O157 Antibody |
|||
| abx021685-1mg | Abbexa | 1 mg | EUR 996 |
|
|||
E. coli O157 Antibody |
|||
| abx021686-1mg | Abbexa | 1 mg | EUR 996 |
|
|||
E. coli O157 Antibody |
|||
| abx021687-1mg | Abbexa | 1 mg | EUR 996 |
|
|||
E. coli O157 Antibody |
|||
| abx021688-1mg | Abbexa | 1 mg | EUR 940 |
|
|||
E. coli O157 Antibody |
|||
| abx021689-1mg | Abbexa | 1 mg | EUR 996 |
|
|||
) E. coli Antibody (HRP) |
|||
| abx022972-1ml | Abbexa | 1 ml | EUR 599 |
|
|||
) E. coli Antibody (FITC) |
|||
| abx022974-1ml | Abbexa | 1 ml | EUR 648 |
|
|||
) E. coli Antibody (Biotin) |
|||
| abx022976-1ml | Abbexa | 1 ml | EUR 599 |
|
|||
E. coli Antibody (HRP) |
|||
| abx022978-1ml | Abbexa | 1 ml | EUR 878 |
|
|||
E. coli Antibody (Biotin) |
|||
| abx022979-1ml | Abbexa | 1 ml | EUR 739 |
|
|||
E. coli O157 Antibody |
|||
| abx024017-1mg | Abbexa | 1 mg | EUR 1010 |
|
|||
 E. coli O 157 |
|||
| abx291002-100mg | Abbexa | 100 mg | EUR 620 |
|
|||
 Benzonase, E. Coli Recombinant |
|||
| 7680-25 | Biovision | EUR 332 | |
Benzonase, E. Coli Recombinant |
|||
| 7680-5 | Biovision | EUR 137 | |
 E. coli O157 antibody |
|||
| 10C-CR1295M3 | Fitzgerald | 100 ug | EUR 392 |
|
Description: Mouse monoclonal E. coli O157 antibody |
|||
E. coli O157 antibody |
|||
| 10-1490 | Fitzgerald | 100 ug | EUR 136 |
|
Description: Mouse monoclonal E. coli O157 antibody |
|||
E. coli O157 antibody |
|||
| 10-1521 | Fitzgerald | 100 ug | EUR 142 |
|
Description: Mouse monoclonal E. coli O157 antibody |
|||
E. coli O157 antibody |
|||
| 10-E12A | Fitzgerald | 100 ug | EUR 385 |
|
Description: Mouse monoclonal E. coli O157 antibody |
|||
 E. coli LexA repressor |
|||
| 01-005 | Sceti | 50 ug | EUR 479 |
|
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
|||
E. coli LexA repressor |
|||
| 01-006 | Sceti | 250 ug | EUR 1184 |
|
Description: The E. coli LexA repressor is available in Europe and for worldwide shipping via Gentaur. |
|||
 TesA, E. coli esterase |
|||
| 0306-1 | AthenaES | 100 Units | EUR 421 |
TesA, E. coli esterase |
|||
| 0306-5 | AthenaES | 500 Units | EUR 1705 |
 E. coli CysH Antibody |
|||
| 30281-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli glk Antibody |
|||
| 32864-05111 | AssayPro | 150 ug | EUR 261 |
 E. Coli ldhA Antibody |
|||
| 32898-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli deoC Antibody |
|||
| 32936-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli Skp Antibody |
|||
| 32971-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli nanA Antibody |
|||
| 33092-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli pykF Antibody |
|||
| 32163-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli GOR Antibody |
|||
| 32540-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli NDK Antibody |
|||
| 32662-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli PPA Antibody |
|||
| 32678-05111 | AssayPro | 150 ug | EUR 261 |
 E. coli DnaJ Antibody |
|||
| 32022-05111 | AssayPro | 150 ug | EUR 261 |
 E. Coli HCP antibody |
|||
| 20R-EG001 | Fitzgerald | 1 ml | EUR 837 |
|
Description: Goat polyclonal E. Coli HCP antibody |
|||
 E. coli GroEL Antibody |
|||
| 20012-05011 | AssayPro | 150 ug | EUR 217 |
 E. Coli Recombinant TRXB |
|||
| 6331-100 | Biovision | EUR 425 | |
 E. Coli Recombinant SlyD |
|||
| 6366-100 | Biovision | EUR 457 | |
) E. coli antibody (FITC) |
|||
| 60-E13 | Fitzgerald | 1 ml | EUR 378 |
|
Description: Rabbit polyclonal E. coli antibody (FITC) conjugated |
|||
) E. coli antibody (biotin) |
|||
| 60-E13B | Fitzgerald | 1 ml | EUR 468 |
|
Description: Rabbit polyclonal E. coli antibody (biotin) conjugated |
|||
) E. coli antibody (HRP) |
|||
| 60-E14 | Fitzgerald | 1 ml | EUR 408 |
|
Description: Rabbit polyclonal E. coli antibody (HRP) conjugated |
|||
 E. coli FimC [His] |
|||
| DAG1666 | Creative Diagnostics | 100 ug | EUR 1027 |
 E. coli Eco [His] |
|||
| DAG1667 | Creative Diagnostics | 50 ug | EUR 1027 |
 E. coli Recombinant IDNK |
|||
| P1050-10 | Biovision | EUR 164 | |
E. coli Recombinant IDNK |
|||
| P1050-50 | Biovision | EUR 381 | |
 Recombinant E. coli, Glucokinase |
|||
| P1054-10 | Biovision | EUR 164 | |
Recombinant E. coli, Glucokinase |
|||
| P1054-50 | Biovision | EUR 381 | |
 E. coli DNA Ligase |
|||
| M1217-100 | Biovision | EUR 321 | |
 E. coli Exonuclease I |
|||
| M1222-100 | Biovision | EUR 251 | |
 E. coli Exonuclease III |
|||
| M1223-100 | Biovision | EUR 267 | |
 E. coli Topoisomerase IV |
|||
| TG2000EC-1 | TopoGen | 250 units | EUR 448 |
E. coli Topoisomerase IV |
|||
| TG2000EC-3 | TopoGen | 500 units | EUR 683 |
E. coli Topoisomerase IV |
|||
| TG2000EC-5 | TopoGen | 1000 units | EUR 1052 |
 E. coli DNA Gyrase |
|||
| TG2000G-1 | TopoGen | 100 units | EUR 324 |
E. coli DNA Gyrase |
|||
| TG2000G-3 | TopoGen | 500 units | EUR 705 |
E. coli DNA Gyrase |
|||
| TG2000G-5 | TopoGen | 1000 units | EUR 1164 |
E. coli DNA Gyrase |
|||
| TG2000G-7 | TopoGen | 2000 units | EUR 1836 |
 ELISA Kit) Human Escherichia coli (E. coli) ELISA Kit |
|||
| abx052493-96tests | Abbexa | 96 tests | EUR 668 |
|
|||
 ELISA Kit) Cow Escherichia coli (E. coli) ELISA Kit |
|||
| abx055785-96tests | Abbexa | 96 tests | EUR 668 |
|
|||
 Protein) E. coli Syndecan 1 (SDC1) Protein |
|||
| 20-abx263542 | Abbexa |
|
|
|
|||
 Protein) E. coli Progesterone Receptor (PGR) Protein |
|||
| 20-abx263552 | Abbexa |
|
|
|
|||
 E. coli 0157:H7 cell protein |
|||
| 30-AE13 | Fitzgerald | 1 ml | EUR 284 |
|
Description: Heat inactivated E. coli O157:H7 cells |
|||
) Recombinant Human RAGE Protein (E. coli) |
|||
| VAng-2906Lsx-1mg | Creative Biolabs | 1 mg | EUR 3597 |
|
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
|||
Recombinant Human RAGE Protein (E. coli) |
|||
| VAng-2906Lsx-200g | Creative Biolabs | 200 µg | EUR 1329 |
|
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
|||
Recombinant Human RAGE Protein (E. coli) |
|||
| VAng-2906Lsx-500g | Creative Biolabs | 500 µg | EUR 2291 |
|
Description: Recombinant Human RAGE (AGER) protein is expressed in E. coli. (Uniprot ID: Q15109) |
|||
 [GST]) Recombinant CMV Protein (E. coli) [GST] |
|||
| VAng-Lsx0035-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CMV [GST], recombinant protein from E. coli. |
|||
) Recombinant Trypanosoma Cruiz Protein (E. coli) |
|||
| VAng-Wyb8373-1mg | Creative Biolabs | 1 mg | EUR 3693 |
|
Description: Trypanosoma Cruiz protein, recombinant protein. |
|||
) Recombinant HIV-2 E gp 36 Protein (E. coli) |
|||
| VAng-0534Lsx-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: HIV type 2 Envelope glycoprotein 36, recombinant protein from E. coli. MW 16 kDa, 1 mg/mL. |
|||
 Protein) E. coli Chaperone Protein Dnaj (DNAJ) Protein |
|||
| 20-abx260479 | Abbexa |
|
|
|
|||
 Protein) E. coli Chaperone Protein SKP (SKP) Protein |
|||
| 20-abx260554 | Abbexa |
|
|
|
|||
 Protein) E. coli Green Fluorescent Protein (GFP) Protein |
|||
| 20-abx260632 | Abbexa |
|
|
|
|||
 (fusion protein) for WB +ve control) Purified Rec. E. Coli Thioredoxin (TrxA, E. coli) (fusion protein) for WB +ve control |
|||
| THRX11-C | Alpha Diagnostics | 100 ul | EUR 286 |
 Antibody) Escherichia coli Serotype O2 (E. coli O2) Antibody |
|||
| abx411330-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 Antibody) Escherichia coli Serotype O15 (E. coli O15) Antibody |
|||
| abx411331-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 Antibody) Escherichia coli Serotype O20 (E. coli O20) Antibody |
|||
| abx411332-02mg | Abbexa | 0.2 mg | EUR 565 |
|
|||
 Cytochalasin E |
|||
| C197-1MG | TOKU-E | 1 mg | EUR 131 |
Cytochalasin E |
|||
| C197-5MG | TOKU-E | 5 mg | EUR 385 |
 Deoxybrevianamide E |
|||
| D083-1MG | TOKU-E | 1 mg | EUR 278 |
Deoxybrevianamide E |
|||
| D083-5MG | TOKU-E | 5 mg | EUR 897 |
 Oligomycin E |
|||
| O021-1MG | TOKU-E | 1 mg | EUR 318 |
Oligomycin E |
|||
| O021-5MG | TOKU-E | 5 mg | EUR 1040 |
 Paraherquamide E |
|||
| P070-0.5MG | TOKU-E | 0.5 mg | EUR 400 |
Paraherquamide E |
|||
| P070-2.5MG | TOKU-E | 2.5 mg | EUR 1325 |
 Phenelfamycin E |
|||
| P078-1MG | TOKU-E | 1 mg | EUR 318 |
Phenelfamycin E |
|||
| P078-5MG | TOKU-E | 5 mg | EUR 1040 |
 Roquefortine E |
|||
| R035-1MG | TOKU-E | 1 mg | EUR 224 |
Roquefortine E |
|||
| R035-5MG | TOKU-E | 5 mg | EUR 708 |
) rHu BMP-2 (E. coli) |
|||
| AK8356-0002 | Akron Biotech | 2µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
| AK8356-0010 | Akron Biotech | 10µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
| AK8356-0100 | Akron Biotech | 100µg | Ask for price |
rHu BMP-2 (E. coli) |
|||
| AK8356-1000 | Akron Biotech | 1mg | Ask for price |
 Antibody) E. coli O157 (9.88) Antibody |
|||
| BNC610207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC610207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF660R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC680207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC680207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF568 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC430207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC430207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF543 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC550207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC550207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF555 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC040207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF405S conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC040207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF405S conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC400207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC400207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF640R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC050207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC050207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF405M conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC470207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC470207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF647 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNUM0207-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against E. coli O157 (9.88), 1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC700207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC700207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF770 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC940207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC940207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF594 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCH0207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCH0207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC800207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC800207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF680 conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC810207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC810207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF680R conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCP0207-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against E. coli O157 (9.88),PerCP conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCR0207-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against E. coli O157 (9.88),RPE conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCA0207-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against E. coli O157 (9.88),APC conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCAP0207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCAP0207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCB0207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNCB0207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),Biotin conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC880207-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNC880207-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against E. coli O157 (9.88),CF488A conjugate, Concentration: 0.1mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNUB0207-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
|||
E. coli O157 (9.88) Antibody |
|||
| BNUB0207-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against E. coli O157 (9.88), Concentration: 0.2mg/mL |
|||
 E. coli Enterotoxin B Antibody |
|||
| abx021678-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
E. coli Enterotoxin B Antibody |
|||
| abx021679-1mg | Abbexa | 1 mg | EUR 606 |
|
|||
E. coli Enterotoxin B Antibody |
|||
| abx021680-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
) E. coli O157 Antibody (FITC) |
|||
| abx021683-1mg | Abbexa | 1 mg | EUR 2332 |
|
|||
 E. coli O157:H7 Antibody |
|||
| abx022980-1mg | Abbexa | 1 mg | EUR 599 |
|
|||
 E. coli Enterotoxin LT Antibody |
|||
| abx023834-1mg | Abbexa | 1 mg | EUR 732 |
|
|||
E. coli Enterotoxin LT Antibody |
|||
| abx023835-1mg | Abbexa | 1 mg | EUR 732 |
|
|||
E. coli Enterotoxin LT Antibody |
|||
| abx023836-1mg | Abbexa | 1 mg | EUR 732 |
|
|||
E. coli Enterotoxin LT Antibody |
|||
| abx023837-1mg | Abbexa | 1 mg | EUR 732 |
|
|||
 E. coli Enterotoxin STp Antibody |
|||
| abx023838-1mg | Abbexa | 1 mg | EUR 878 |
|
|||
E. coli Enterotoxin STp Antibody |
|||
| abx023839-1mg | Abbexa | 1 mg | EUR 878 |
|
|||
E. coli Enterotoxin STp Antibody |
|||
| abx023840-1mg | Abbexa | 1 mg | EUR 878 |
|
|||
 Antibody) E. coli Tryptophanase (Tnase) Antibody |
|||
| 33517-05111 | AssayPro | 150 ug | EUR 261 |
) Insulin, human recombinant (E. coli) |
|||
| 4772-25 | Biovision | EUR 452 | |
Insulin, human recombinant (E. coli) |
|||
| 4772-5 | Biovision | EUR 207 | |
 Mouse antibody for E. coli |
|||
| 1063 | Virostat | 100 ug | EUR 365.38 |
|
Description: This is Mouse monoclonal FITC conjugated antibody against E coli O157 for WB, ELISA. |
|||
) E. coli antibody (K99 Pilus) |
|||
| 10-E20A | Fitzgerald | 500 ug | EUR 493 |
|
Description: Mouse monoclonal E. coli antibody (K99 Pilus) |
|||
 E. coli RecQ DNA helicase |
|||
| 01-003 | Sceti | 50 ug | EUR 479 |
|
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
|||
E. coli RecQ DNA helicase |
|||
| 01-004 | Sceti | 250? g | EUR 1549 |
|
Description: The E. coli RecQ DNA helicase is available in Europe and for worldwide shipping via Gentaur. |
|||
 E. coli Glycerol Kinase Antibody |
|||
| 32699-05111 | AssayPro | 150 ug | EUR 261 |
) E. coli O157 antibody (FITC) |
|||
| 61C-CR1295M1F | Fitzgerald | 100 ug | EUR 408 |
|
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
|||
E. coli O157 antibody (FITC) |
|||
| 61C-CR1295M4F | Fitzgerald | 100 ug | EUR 468 |
|
Description: Mouse monoclonal E. coli O157 antibody (FITC) |
|||
 E. Coli Recombinant Thioredoxin 1 |
|||
| 6329-50 | Biovision | EUR 403 | |
 E. coli O157:H7 antibody |
|||
| 70-XG13 | Fitzgerald | 1 mg | EUR 612 |
|
Description: Affinity purified Goat polyclonal E. coli O157:H7 antibody. |
|||
 Uricase from E. coli, Recombinant |
|||
| DIA-415 | Creative Enzymes | 5KU | EUR 378 |
 E. coli β-gal peptide |
|||
| DAG2441 | Creative Diagnostics | 0.05 mg | EUR 485 |
 Native E. Coli O 158 |
|||
| DAGA-3025 | Creative Diagnostics | 0.1 ml | EUR 715 |
MLT and 5-HIAA ranges within the 222 mg/kg group considerably elevated in comparison with these within the CT and CT+111 mg/kg teams. As well as, the AADC and AA-NAT gene expression ranges within the duodenum and jejunum had been elevated by the supplementation of RP 5-HTP. Rumen-protected 5-hydroxytryptophan promoted melatonin synthesis within the pineal gland and intestinal tract through the pure gentle interval.